Benzinga | Nov 10, 2020 04:03PM EST

Gossamer Bio Q3 EPS $(0.80) Beats $(0.85) Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(0.85) by 5.88 percent. This is unchanged from the same period last year.